MedPath

Registry of Patients With Hematologic Disease and COVID-19 in Russia

Completed
Conditions
Coronavirus Infection and Hematologic Diseases
Registration Number
NCT04422470
Lead Sponsor
National Research Center for Hematology, Russia
Brief Summary

This is an observational prospective cohort study to evaluate the clinical course and outcomes of COVID-19 and the underlying disease in patients with hematologic disease (malignant or non-malignant).

Detailed Description

This is a web-based registry. After registration, physicians from hematology clinical centers and hospitals in Russia will receive access to the web platform for clinical trial management to fill in the online data collection form in a de-identified manner. This form includes questions about general clinical history of hematologic disease, manifestation, treatment, and the course of COVID-19, concomitant conditions, consequences on the hematologic disease, short-term and long-term outcomes. It will take approximately 10 min to answer the questions. Patients will be followed for 30 days after COVID-19 diagnosis and up to 6 months for hematologic disease outcomes and overall survival assessment.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
666
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
30-day all-cause mortality30 day

Rate of death from any cause

Secondary Outcome Measures
NameTimeMethod
Relapse or progression of hematologic disease30 day, 90 day and 180 day

Rate of relapse or progression of hematologic disease

Overall survival30 day, 90 day and 180 day

Number of patients alive

COVID-19 complications30 day

Rate of COVID-19 complications

Mechanical ventilation / O2 requirement30 day

Rate of mechanical ventilation / O2 requirement

Risk factors30 day, 90 day and 180 day

Putative risk factors for the severity and lethality of COVID-19

ICU admission30 day

Rate of ICU admission

Trial Locations

Locations (13)

Regional Clinical Hospital No1

🇷🇺

Ekaterinburg, Russian Federation

Republican Clinical Hospital of Tatarstan

🇷🇺

Kazan, Russian Federation

City Hospital n.a. V.V. Veresaev

🇷🇺

Moscow, Russian Federation

Clinical Hospital n.a. S.P. Botkin

🇷🇺

Moscow, Russian Federation

N.V. Sklifosovsky Emergency Institute

🇷🇺

Moscow, Russian Federation

National Research Center for Hematology

🇷🇺

Moscow, Russian Federation

Regional Clinical Hospital N.A. Semashko

🇷🇺

Nizhny Novgorod, Russian Federation

Regional Hospital

🇷🇺

Novosibirsk, Russian Federation

Regional Clinical Hospital

🇷🇺

Yaroslavl, Russian Federation

RM Gorbacheva Research Institute of Pediatric Oncology, Hematology and Transplantation, Pavlov University

🇷🇺

Saint Petersburg, Russian Federation

Scroll for more (3 remaining)
Regional Clinical Hospital No1
🇷🇺Ekaterinburg, Russian Federation

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.